At a glance

Few follicles, uneven or slow growth, or a low egg count at retrieval can change the plan mid-cycle. Here is what monitoring findings mean, what a clinician may adjust, and how to keep travel and records flexible.

You are partway through stimulation, and a scan shows fewer follicles than you expected, or a group that is growing at different speeds. Or you have already had retrieval and been told that fewer eggs were collected than the follicle count suggested. In each case, the useful question is not whether the cycle is “good” or “bad”, but what the monitoring information changes about the next decision.

Response to stimulation varies between patients, and stimulation protocols and trigger timing can be adjusted based on monitoring. Those adjustments are clinical decisions made by your treating clinician, usually in conversation with you. This guide explains how the findings are read, what kinds of adjustment are possible, and how to keep your travel and records workable if the plan shifts.

How monitoring findings are read together

During stimulation, clinics typically combine two kinds of information: ultrasound appearances and blood hormone levels. Neither is interpreted alone.

  • Follicle count gives a sense of how many follicles are developing. A low count for your age and starting situation is one signal among several.
  • Follicle size shows maturity progress. A cohort that is close in size tends to be easier to time than one with a wide spread.
  • Growth trend matters more than any single scan. Two measurements several days apart tell your clinician whether the group is progressing, plateauing or diverging.
  • Hormone levels help interpret what the scan shows and inform dose and trigger decisions.

This is why a single disappointing scan is not usually the whole story. Your clinician is reading a trajectory, and the next step depends on where that trajectory seems to be heading. If you want a broader picture of how monitoring appointments are sequenced, see what to expect during IVF cycle monitoring in Thailand.

When growth is slow or uneven

Slow growth and uneven follicle size are common reasons for a plan to change mid-cycle. Broadly, a clinician may consider:

  • Continuing stimulation for longer so that slower follicles have time to catch up, if the leading follicles are not yet ready.
  • Adjusting medication — for example a dose change — based on the trend rather than a single reading.
  • Changing trigger timing so that retrieval is scheduled when the largest group is most likely to be ready, accepting that smaller follicles may not contribute.
  • Accepting a smaller cohort and proceeding, if the clinician judges that waiting longer is unlikely to add useful follicles.

None of these is automatically right. The trade-offs differ: waiting can help some follicles mature but may also let others over-mature, and a larger dose is not a guarantee of a larger response. Ask your clinician to explain which trade-off is driving the recommendation in your case.

When very few follicles are developing

A low follicle count during stimulation can prompt a more fundamental conversation. Options that clinicians sometimes discuss include continuing with adjusted medication, cancelling the cycle, or converting to a different approach such as freezing eggs or embryos rather than proceeding to a fresh transfer. Which of these is reasonable depends on your history, your response so far, and what you want from the cycle.

Cancelling is not a failure of effort; it can be a way to avoid a retrieval with a very low chance of yielding usable eggs, or to reconsider the protocol for a later attempt. Equally, proceeding can be the right choice when the clinician expects at least some usable eggs. If you are travelling specifically for treatment and have a known low reserve, it is worth reading planning an IVF trip to Thailand with diminished ovarian reserve before you book, because it frames the questions to settle in advance.

At retrieval: low egg numbers, empty follicles and immature eggs

Retrieval can produce fewer eggs than the scan suggested. Three terms come up, and they mean different things:

  • Low oocyte yield means fewer eggs were collected than expected from the number of follicles seen.
  • Empty follicle describes a follicle that was aspirated but yielded no egg. This can happen for technical or biological reasons, and it is not something you can control from outside.
  • Immature eggs are eggs collected before they reached the stage needed for fertilisation. Some may mature in the laboratory, depending on the clinic’s practice.

After retrieval, your clinician may review the stimulation record, the trigger timing and the laboratory report to understand what happened and whether a different approach is worth considering next time. Ask for that review as a conversation, not just a number: what would you change, and what would you keep the same?

Where PGT fits, and where it does not

If you are considering preimplantation genetic testing, a low-response cycle changes the arithmetic. PGT-A assesses chromosome number in cells sampled from an embryo, and biopsy carries a risk of damage that can prevent further development. Testing also has limitations and can produce incorrect findings, and it does not guarantee a successful pregnancy or a healthy child. With few eggs and therefore few embryos, the number available for biopsy may be small, and the value of testing depends on your individual situation. PGT-M and PGT-SR address different questions — a known monogenic condition and a chromosomal structural rearrangement, respectively — and suitability should be discussed with your treating team and a genetic counsellor.

If a result is reported as mosaic, that is an inference from intermediate findings in the sampled cells, and technical factors can contribute. A sampled result does not establish the cell composition of the whole embryo, so the uncertainty should be discussed directly with your clinician and genetic counsellor.

Questions to put to your clinician at each decision point

You do not need a long list at every scan. A few targeted questions tend to be more useful:

  • What has changed since the last scan, and what would you expect to see at the next one?
  • What are we optimising for — more follicles, better synchrony, or earlier retrieval?
  • If we wait, what is the risk of over-maturing the leading follicles?
  • If we proceed now, how many eggs would you realistically expect, and how does that affect our plan for testing or transfer?
  • If this cycle is cancelled or converted, what would you change next time, and what would stay the same?
  • What should I do about medication timing if the plan changes today?

Medication instructions come from your treating clinician or clinic, not from a coordination service. If you are unsure about a dose or timing, contact the clinic directly rather than adjusting on your own.

Keeping travel and records flexible

Mid-cycle changes can move your retrieval date, which affects flights, accommodation and how long you stay in Thailand. Practical steps that help:

  • Keep the return flight changeable until retrieval and the fertilisation report are behind you.
  • Record approximate dates of scans, dose changes and results as they happen, so a later review has a clear timeline.
  • Ask the clinic how they will contact you if a same-day decision is needed, and confirm who on your side is the named contact.
  • If you are considering a fresh or frozen transfer, note that a low-yield cycle may make a freeze-all approach more likely to be discussed; fresh versus frozen transfer planning in Thailand sets out the pathway differences.

If you are coordinating from abroad, it can help to have someone organise your records and relay non-clinical questions to the hospital while you focus on the clinical conversation. That is a communication role, not a clinical one: interpretation of results and all treatment decisions stay with your treating team. For a sense of how monitoring and communication fit together across a trip, see communicating with your clinic during ovarian stimulation in Thailand.

If the plan changes and you need help requesting records, confirming an appointment or arranging a remote consultation, you can request a case review and set out what has changed so far.

Frequently asked questions

Does a low follicle count mean the cycle will be cancelled?

Not necessarily. A low count is one finding among several, and clinicians weigh it alongside growth trend, hormone levels and your history. Continuing with adjustments, cancelling or converting the cycle are all possibilities that your treating clinician should discuss with you rather than decide silently.

Can I ask my clinician about my individual chances after a low-yield retrieval?

Yes. Patients can and should ask licensed clinicians about diagnosis, options, risks, reports and individual chances. A coordination service cannot answer those questions, but it can help you organise records and put the request to the clinic.

Evidence trail

Sources & verification

Review current primary information and reconfirm provider services, fees and eligibility before booking.

01HFEA: Pre-implantation genetic testing for aneuploidy (PGT-A) ↗02HFEA PGT-A frequently asked questions (checked 2026-10-15) ↗03HFEA: PGT-M and PGT-SR ↗04ASRM: Clinical management of mosaic PGT-A results (2023) ↗

Your next practical step

Bring your coordination questions.

Ask about appointments, records, travel or the practical arrangements for your visit.

Ask about coordination support →